Craig Hopkinson
Chief Tech/Sci/R&D Officer chez ALKERMES PLC
Fortune : 3 M $ au 31/03/2024
Profil
Craig C. Hopkinson est Chief Medical Officer et EVP-Research & Development chez Alkermes Plc. Dans le passé, le Dr Hopkinson a occupé le poste de Senior VP & Head-Global Medical Affairs chez Vertex Pharmaceuticals, Inc. et celui de President-Eisai Value Maximization Systems chez Eisai, Inc. Le Dr Hopkinson a obtenu un diplôme de premier cycle à l'Université de l'État libre.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/02/2024 | 109 709 ( 0,07% ) | 3 M $ | 31/03/2024 |
Postes actifs de Craig Hopkinson
| Sociétés | Poste | Début |
|---|---|---|
| ALKERMES PLC | Chief Tech/Sci/R&D Officer | 30/05/2017 |
Anciens postes connus de Craig Hopkinson
| Sociétés | Poste | Fin |
|---|---|---|
| ALBIREO PHARMA, INC. | Director/Board Member | 02/03/2023 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | 01/01/2020 |
| VERTEX PHARMACEUTICALS INCORPORATED | Chief Tech/Sci/R&D Officer | 01/05/2017 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | President | 01/12/2012 |
Formation de Craig Hopkinson
| University of the Free State | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| ALKERMES PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
